HRMY HARMONY BIOSCIENCES HOLDINGS
2026Q1 · CUSIP 413197104 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
307
Δ holders QoQ
-15
Breadth percentile
Top 90%
Whale holders
157
Δ whales
-6
Inst. holding value
$1.5B
New positions
44
Closed positions
59
Price momentum (1Q)
-19.2%
Put / Call
5/4
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 15% | +1.2% | -7.7% |
| 2025Q1 | Top 12% | +1.4% | -5.3% |
| 2024Q2 | Top 19% | -5.6% | +1.1% |
| 2022Q4 | Top 9% | -26.3% | -33.4% |
| 2022Q3 | Top 6% | -11.4% | -37.1% |
| 2022Q1 | Top 4% | +11.1% | +33.9% |
| 2021Q4 | Top 10% | -0.4% | +15.8% |
| 2021Q3 | Top 9% | -2.7% | -3.1% |
| 2021Q2 | Top 10% | +35.0% | +20.4% |
Options Sentiment
Put holders
5
QoQ: +2
Call holders
4
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
14.2
EPS (TTM)
$2.48
EPS YoY
-5.3%
Revenue (TTM)
$0.9B
Revenue YoY
+20.7%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)